These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 18063672)

  • 1. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
    Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
    Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.
    Lakota K; Thallinger GG; Sodin-Semrl S; Rozman B; Ambrozic A; Tomsic M; Praprotnik S; Cucnik S; Mrak-Poljsak K; Ceribelli A; Cavazzana I; Franceschini F; Vencovsky J; Czirják L; Varjú C; Steiner G; Aringer M; Stamenkovic B; Distler O; Matucci-Cerinic M; Kveder T
    Arthritis Res Ther; 2012 Jan; 14(1):R2. PubMed ID: 22226402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
    Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
    Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.
    Cavazzana I; Ceribelli A; Quinzanini M; Scarsi M; Airò P; Cattaneo R; Franceschini F
    Lupus; 2008 Aug; 17(8):727-32. PubMed ID: 18625650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
    Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
    Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of diffuse cutaneous systemic sclerosis with anti-Ku and anti-centromere antibodies.
    Ohashi S; Ueda-Hayakawa I; Isei T; Okamoto H
    J Dermatol; 2013 Jul; 40(7):558-61. PubMed ID: 23663134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.
    Hoa S; Hudson M; Troyanov Y; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ;
    Medicine (Baltimore); 2016 Aug; 95(35):e4713. PubMed ID: 27583908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.
    Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):96-102. PubMed ID: 23101460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.
    Kaji K; Fertig N; Medsger TA; Satoh T; Hoshino K; Hamaguchi Y; Hasegawa M; Lucas M; Schnure A; Ogawa F; Sato S; Takehara K; Fujimoto M; Kuwana M
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):575-84. PubMed ID: 24023044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
    Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
    Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against Ku protein in sera from patients with autoimmune diseases.
    Yaneva M; Arnett FC
    Clin Exp Immunol; 1989 Jun; 76(3):366-72. PubMed ID: 2665976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological associations of anti-Ku antibody.
    Cooley HM; Melny BJ; Gleeson R; Greco T; Kay TW
    J Rheumatol; 1999 Mar; 26(3):563-7. PubMed ID: 10090163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
    Graf SW; Hakendorf P; Lester S; Patterson K; Walker JG; Smith MD; Ahern MJ; Roberts-Thomson PJ
    Int J Rheum Dis; 2012 Feb; 15(1):102-9. PubMed ID: 22324953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.